Co-Authors
This is a "connection" page, showing publications co-authored by Simon Tiberi and Antonio Spanevello.
Connection Strength
0.366
-
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
Score: 0.057
-
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020 11; 26(11):2709-2712.
Score: 0.056
-
Tuberculosis in the time of COVID-19: quality of life and digital innovation. Eur Respir J. 2020 08; 56(2).
Score: 0.056
-
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
Score: 0.056
-
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. Eur Respir J. 2018 07; 52(1).
Score: 0.048
-
Tuberculosis elimination: where are we now? Eur Respir Rev. 2018 Jun 30; 27(148).
Score: 0.048
-
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 05; 49(5).
Score: 0.045